HRAS and Alzheimer disease: Here, studying the brain tissue samples from individuals at different stages of the disease, we found that FT is abnormally upregulated in AD, leading to subsequent elevation of protein farnesylation and overactivation of downstream signaling pathways, as evidenced by an increase in membrane-associated H-Ras and its downstream ERK phosphorylation, although other factors could not be excluded.